UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response to immunotherapy plus anti‐angiogenic agent combination challenges hepatocellular carcinoma prognostic scores

Hepatology communications, 2022-12, Vol.6 (12), p.3595-3596

2022

Volltextzugriff (PDF)

Surgical treatment of tertiary hyperparathyroidism: does one fit for all?

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1226917-1226917

2023

Volltextzugriff (PDF)

An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma

Expert opinion on pharmacotherapy, 2017-09, Vol.18 (14), p.1467-1476

2017

Volltextzugriff (PDF)

Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

Liver cancer (Basel ), 2019-11, Vol.8 (6), p.457-467

2019

Volltextzugriff (PDF)

Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?

Therapeutic Advances in Gastroenterology, 2018-01, Vol.11, p.1756284818812358-1756284818812358

2018

Volltextzugriff (PDF)

How to assess the efficacy or failure of targeted therapy:deciding when to stop sorafenib in hepatocellular carcinoma

World journal of hepatology, 2016-12, Vol.8 (35), p.1541-1546

2016

Volltextzugriff (PDF)

Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma

Diagnostics (Basel), 2023-03, Vol.13 (7), p.1303

2023

Volltextzugriff (PDF)

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments

World journal of hepatology, 2016-06, Vol.8 (17), p.703-715

2016

Volltextzugriff (PDF)

Usefulness of the MESH score in a European hepatocellular carcinoma cohort

World journal of hepatology, 2017-05, Vol.9 (15), p.711-714

2017

Volltextzugriff (PDF)

COSMIC-312, a disappointing result—is that so surprising?

Annals of translational medicine, 2024-08, Vol.12 (4), p.59-59

2024

Volltextzugriff (PDF)

ALBI‐based BCLC nomogram: A new or an additional prognostic tool?

Liver international, 2020-07, Vol.40 (7), p.1785-1786

2020

Volltextzugriff (PDF)

Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process

Journal of hepatology, 2015-04, Vol.62 (4), p.855-862

2015

Volltextzugriff (PDF)

The “six-and-twelve score” for TACE treatment: Does it really help us?

Journal of hepatology, 2019-11, Vol.71 (5), p.1051-1052

2019

Volltextzugriff (PDF)

Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort

Journal of hepatology, 2015-02, Vol.62 (2), p.492-493

2015

Volltextzugriff (PDF)

Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study

European journal of gastroenterology & hepatology, 2024-07

2024

Volltextzugriff (PDF)

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis

European journal of nuclear medicine and molecular imaging, 2016-04, Vol.43 (4), p.635-643

2016

Volltextzugriff (PDF)

Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16195-e16195

2024

Volltextzugriff (PDF)

Response to ‘the flexible therapeutic approach to the BCLC B stage’: Time for scoring systems?

Journal of hepatology, 2018-01, Vol.68 (1), p.214-215

2018

Volltextzugriff (PDF)

HCV screening in a tertiary french hospital: just do it

Journal of hepatology, 2022-07, Vol.77, p.S547-S548

2022

Volltextzugriff (PDF)

Hepatocellular carcinoma scoring and staging systems. Do we need new tools?

Journal of hepatology, 2016-06, Vol.64 (6), p.1449-1450

2016

Volltextzugriff (PDF)

Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?

Annals of translational medicine, 2020-12, Vol.8 (23), p.1616-1616

2020

Volltextzugriff (PDF)

Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective

Targeted oncology, 2023-01, Vol.18 (1), p.51-76

2023

Volltextzugriff (PDF)

Sofosbuvir as backbone of interferon free treatments

Digestive and liver disease, 2014-12, Vol.46, p.S212-S220

2014

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(63)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Gastroenterology & Hepatology
(35)
Humans
(28)
Hepatocellular Carcinoma
(17)
Prognosis
(14)
Female
(11)
Male
(11)
Life Sciences
(10)
Middle Aged
(9)
Aged
(8)
Treatment Outcome
(8)
Liver Neoplasms
(7)
Neoplasm Staging
(7)
Transarterial Chemoembolization
(7)
Antiviral Agents - Therapeutic Use
(6)
Carcinoma, Hepatocellular
(6)
Carcinoma, Hepatocellular - Pathology
(6)
Gastroenterology And Hepatology
(6)
Liver Cancer
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Response to immunotherapy plus anti‐angiogenic agent combination challenges hepatocellular carcinoma prognostic scores

Surgical treatment of tertiary hyperparathyroidism: does one fit for all?

An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma

Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?

How to assess the efficacy or failure of targeted therapy:deciding when to stop sorafenib in hepatocellular carcinoma

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study

Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments

Usefulness of the MESH score in a European hepatocellular carcinoma cohort

COSMIC-312, a disappointing result—is that so surprising?

ALBI‐based BCLC nomogram: A new or an additional prognostic tool?

Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process

The “six-and-twelve score” for TACE treatment: Does it really help us?

Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort

Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis

Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC)

Response to ‘the flexible therapeutic approach to the BCLC B stage’: Time for scoring systems?

HCV screening in a tertiary french hospital: just do it

Hepatocellular carcinoma scoring and staging systems. Do we need new tools?

THU-475 Tumor burden incorporating AFP improves survival prediction for patients with HCC undergoing TACE: an international multicentre observational study

Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?

Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective

Sofosbuvir as backbone of interferon free treatments

Suchergebnisse filtern